Can Treg therapy prevent GVHD?

Blood

Volumn 117, Issue 3, 2011, Pages 751-752

  Komanduri, Krishna V ^a   Champlin, Richard E ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; CELL THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LEUKEMIA; NONHUMAN; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 78751691629     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-317305     Document Type: Note

References (10)

1. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expandedTregulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3):1061-1070.
2. Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology. 1970;18(5):723-737.
3. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155(3):1151-1164.
4. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S. Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196(3):389-399. (Pubitemid 34875667)
5. Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493-3499.
6. Edinger M, Hoffmann P, Ermann J, et al. CD4+CD25+ regulatoryTcells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine. 2003;9(9):1144-1150. (Pubitemid 37173698)
7. Godfrey WR, Spoden DJ, Ge YG, et al. Cord blood CD4(+)CD25(+)- derivedTregulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood. 2005;105(2):750-758.
8. Escalon MP, Komanduri KV. Cord blood transplantation: evolving strategies to improve engraftment and immune reconstitution. Curr Opin Oncol. 2010;22(2):122-129.
9. Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood. 2009;114(19):4293-4299.
10. Zeiser R, Nguyen VH, Beilhack A, et al. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood. 2006;108(1):390-399. (Pubitemid 43990654)